184 related articles for article (PubMed ID: 29222138)
21. Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy.
Shimada YJ; Raita Y; Liang LW; Maurer MS; Hasegawa K; Fifer MA; Reilly MP
Circ Heart Fail; 2021 Jul; 14(7):e007849. PubMed ID: 34192899
[TBL] [Abstract][Full Text] [Related]
22. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
23. Proteomics Profiling Reveals Insulin-Like Growth Factor 1, Collagen Type VI α-2 Chain, and Fermitin Family Homolog 3 as Potential Biomarkers of Plaque Erosion in ST-Segment Elevated Myocardial Infarction.
Liu J; Wang S; Hou J; Cai H; Pan W; Dong H; Sun R; Dong H; Fang S; Yu B
Circ J; 2020 May; 84(6):985-993. PubMed ID: 32350230
[TBL] [Abstract][Full Text] [Related]
24. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
Addona TA; Shi X; Keshishian H; Mani DR; Burgess M; Gillette MA; Clauser KR; Shen D; Lewis GD; Farrell LA; Fifer MA; Sabatine MS; Gerszten RE; Carr SA
Nat Biotechnol; 2011 Jun; 29(7):635-43. PubMed ID: 21685905
[TBL] [Abstract][Full Text] [Related]
25. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.
Liu RX; Thiessen-Philbrook HR; Vasan RS; Coresh J; Ganz P; Bonventre JV; Kimmel PL; Parikh CR
Transl Res; 2021 Dec; 238():49-62. PubMed ID: 34343625
[TBL] [Abstract][Full Text] [Related]
26. Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.
Hjort M; Eggers KM; Lindhagen L; Baron T; Erlinge D; Jernberg T; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
Clin Biochem; 2021 Dec; 98():17-23. PubMed ID: 34496288
[TBL] [Abstract][Full Text] [Related]
27. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
28. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645
[TBL] [Abstract][Full Text] [Related]
29. Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections.
Wei BR; Simpson RM; Johann DJ; Dwyer JE; Prieto DA; Kumar M; Ye X; Luke B; Shive HR; Webster JD; Hoover SB; Veenstra TD; Blonder J
J Proteome Res; 2012 Mar; 11(3):1561-70. PubMed ID: 22214408
[TBL] [Abstract][Full Text] [Related]
30. Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction.
Maag E; Kulasingam A; Grove EL; Pedersen KS; Kristensen SD; Hvas AM
Sci Rep; 2021 Jul; 11(1):13787. PubMed ID: 34215806
[TBL] [Abstract][Full Text] [Related]
31. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.
Klingenberg R; Aghlmandi S; Liebetrau C; Räber L; Gencer B; Nanchen D; Carballo D; Akhmedov A; Montecucco F; Zoller S; Brokopp C; Heg D; Jüni P; Marti Soler H; Marques-Vidal PM; Vollenweider P; Dörr O; Rodondi N; Mach F; Windecker S; Landmesser U; von Eckardstein A; Hamm CW; Matter CM; Lüscher TF
Eur Heart J; 2017 Dec; 38(47):3493-3502. PubMed ID: 29155984
[TBL] [Abstract][Full Text] [Related]
32. Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study.
Steggerda RC; Geluk CA; Brouwer W; van Rossum AC; Ten Berg JM; van den Berg MP
Int J Cardiovasc Imaging; 2015 Apr; 31(4):831-9. PubMed ID: 25638485
[TBL] [Abstract][Full Text] [Related]
33. Emerging Affinity Reagents for High Throughput Proteomics: Trust, but Verify.
Benson MD; Ngo D; Ganz P; Gerszten RE
Circulation; 2019 Nov; 140(20):1610-1612. PubMed ID: 31710523
[No Abstract] [Full Text] [Related]
34. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients.
Kakimoto Y; Ito S; Abiru H; Kotani H; Ozeki M; Tamaki K; Tsuruyama T
J Am Heart Assoc; 2013 Dec; 2(6):e000565. PubMed ID: 24342996
[TBL] [Abstract][Full Text] [Related]
35. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
[TBL] [Abstract][Full Text] [Related]
36. Serum Protein Changes in Pediatric Sepsis Patients Identified With an Aptamer-Based Multiplexed Proteomic Approach.
Shubin NJ; Navalkar K; Sampson D; Yager TD; Cermelli S; Seldon T; Sullivan E; Zimmerman JJ; Permut LC; Piliponsky AM
Crit Care Med; 2020 Jan; 48(1):e48-e57. PubMed ID: 31714400
[TBL] [Abstract][Full Text] [Related]
37. Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery.
Silbiger VN; Luchessi AD; Hirata RD; Neto LG; Pastorelli CP; Ueda EK; dos Santos ES; Pereira MP; Ramos R; Sampaio MF; Armaganijan D; Paik SH; Murata Y; Ooi GT; Ferguson EW; Hirata MH
Clin Chim Acta; 2011 May; 412(11-12):1086-93. PubMed ID: 21356205
[TBL] [Abstract][Full Text] [Related]
38. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
[TBL] [Abstract][Full Text] [Related]
39. Release of tissue-specific proteins into coronary perfusate as a model for biomarker discovery in myocardial ischemia/reperfusion injury.
Cordwell SJ; Edwards AV; Liddy KA; Moshkanbaryans L; Solis N; Parker BL; Yong AS; Wong C; Kritharides L; Hambly BD; White MY
J Proteome Res; 2012 Apr; 11(4):2114-26. PubMed ID: 22250753
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury.
Wernly B; Fuernau G; Masyuk M; Muessig JM; Pfeiler S; Bruno RR; Desch S; Muench P; Lichtenauer M; Kelm M; Adams V; Thiele H; Eitel I; Jung C
Sci Rep; 2019 Dec; 9(1):18367. PubMed ID: 31797997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
